Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00248482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Cisplatin
DRUG: Gleevec™
DRUG: irinotecan

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]
[object Object]